Trump, Dow and Stock
Digest more
A sharp drop for Intel helps tug the US stock market
Digest more
Actions speak louder than words, and investors piling $7.8 trillion into money market funds pretty clearly shows they're worried about the stock market. Depending on your investing time frame, historical trends can be your friend or foe.
Retail traders parse fresh funding talk, a Walmart pact, and a cautious Wall Street reset for this hydrogen player, today, Jan. 22, 2026.
Investor's Business Daily on MSN
Stock market today: Dow slumps 250 points, but Nasdaq shrugs off Intel tumble, turns higher (live coverage)
The Dow Jones index sinks Friday. Applied Digital surges on AI factory news while a rocket stock takes off.
Today, Jan. 23, 2026, profit taking and fresh glioblastoma survival data weighed on a soaring biotech stock. ImmunityBio ( IBRX 12.13%), an immunity-focused biotech, closed Friday’s session at $6.45, down 12.13%. The stock is still up 63.29% in the past five days and 207.14% in the past month.
The U.S. stock market finished its zigzag week full of tariff threats and cancellations with a quiet and tentative close.
Live Updates Get The Best SPDR S&P 500 ETF Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top analysis on SPDR S&P 500 ETF, market updates, and brand-new stock recommendations delivered directly to your inbox.
Today, Jan. 22, 2026, investors are weighing blockbuster subscriber and revenue growth against cautious guidance and a massive Warner bid.
The first place investors should look for signs of stress in the equity market is credit markets. Despite this week’s asset-price volatility, triggered by the Greenland crisis, looking at those credit markets there’s not much evidence of genuine anxiety at present.